Circulating enterolactone and prostate cancer risk: a Nordic nested case-control study.
Stattin P, Adlercreutz H, Tenkanen L, Jellum E, Lumme S, Hallmans G, Harvei S, Teppo L, Stumpf K, Luostarinen T, Lehtinen M, Dillner J, Hakama M.
Stattin P, et al.
Int J Cancer. 2002 May 1;99(1):124-9. doi: 10.1002/ijc.10313.
Int J Cancer. 2002.
PMID: 11948503
Free article.